Social networks
24,177 1,002 6,788 3,608 23,274Activities
Technologies
Entity types
Location
3 More London Riverside, 3 More London Pl, London SE1 2RE, UK
London
United Kingdom
Employees
Scale: 51-200
Estimated: 187
Engaged corporates
28Added in Motherbase
5 years, 7 months agoEvaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry
Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions.
Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action:
Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential.
EvaluatePharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2026, company financials, pipelines, deals and more. @EvaluatePharma
EvaluateMedTech - tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company financials and more.
Evaluate Custom Solutions - improve your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence.
Explore Evaluate at www.evaluate.com
Twitter: @EvaluatePharma
pharma business analysis, pharma licensing deals, pharma consensus forecasts, biotech business analysis, pharma competitive intelligence, medtech consensus forecasts, pharma business developement, pharma, biotech, medtech news, pharma R&D analysis, and pharma data
Trusted commercial intelligence, consensus forecasts, Vantage news and analysis for pharma, biotech and medtech industry - Explore Evaluate
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 25 Apr 2018 | | |
MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Jun 2019 | | |
Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Other 30 Jan 2023 | | |
Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 1 Aug 2017 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 6 Jun 2019 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 8 Oct 2019 | | |
Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Mar 2019 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Feb 2020 | | |
Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Other 13 Jan 2021 | | |
London Stock Exchange Finance, Financial Services | London Stock Exchange Finance, Financial Services | Not capitalistic Not partnership Event 27 Jul 2020 | |